BINEX Co. Ltd Total Assets
BINEX Co. Ltd total assets. Based on the latest financial reports, BINEX Co. Ltd (053030) holds total assets worth ₩304.35 Billion KRW (≈ $206.25 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BINEX Co. Ltd (053030) total market value for the company's overall valuation and market capitalisation.
Total Assets of BINEX Co. Ltd (2004–2024)
Total assets of BINEX Co. Ltd from 2004 to 2024. This chart illustrates how BINEX Co. Ltd's total assets have evolved over time, based on quarterly financial data. See latest BINEX Co. Ltd stock price today for real-time trading data and today's change.
BINEX Co. Ltd - Asset Composition Analysis
BINEX Co. Ltd Total Assets Breakdown (December 2024)
BINEX Co. Ltd total assets breakdown as of December 2024. BINEX Co. Ltd's total assets of ₩304.35 Billion consist of 33.1% current assets and 66.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩-282.74 Million | 9.2% |
| Accounts Receivable | ₩16.42 Billion | 5.9% |
| Inventory | ₩30.98 Billion | 11.1% |
| Property, Plant & Equipment | ₩132.53 Billion | 47.4% |
| Intangible Assets | ₩21.15 Billion | 7.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2004–2024)
This chart illustrates how BINEX Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BINEX Co. Ltd working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BINEX Co. Ltd's current assets represent 33.1% of total assets in 2024, an increase from 0.0% in 2004.
- Cash Position: Cash and equivalents constituted 9.2% of total assets in 2024, up from 7.5% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 6.0% in 2004.
- Asset Diversification: The largest asset category is property, plant & equipment at 47.4% of total assets.
BINEX Co. Ltd Competitors by Total Assets
Key competitors of BINEX Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GeneBioTech Co. Ltd
KQ:086060
|
Korea | ₩80.28 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩575.39 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩267.18 Billion |
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.92 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩125.25 Billion |
|
Aprogen Healthcare & Games Inc
KQ:109960
|
Korea | ₩324.89 Billion |
BINEX Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 0.84 | 4.40 |
| Quick Ratio | 0.99 | 0.52 | 3.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩40.93 Billion | ₩-15.24 Billion | ₩91.74 Billion |
BINEX Co. Ltd - Advanced Valuation Insights
This section examines the relationship between BINEX Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.7% |
| Total Assets | ₩279.39 Billion |
| Market Capitalization | $123.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values BINEX Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: BINEX Co. Ltd's assets grew by 8.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BINEX Co. Ltd (2004–2024)
The table below shows the annual total assets of BINEX Co. Ltd from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩279.39 Billion ≈ $189.34 Million |
+8.71% |
| 2023-12-31 | ₩257.01 Billion ≈ $174.17 Million |
-13.87% |
| 2022-12-31 | ₩298.41 Billion ≈ $202.23 Million |
+9.51% |
| 2021-12-31 | ₩272.49 Billion ≈ $184.66 Million |
+0.89% |
| 2020-12-31 | ₩270.09 Billion ≈ $183.04 Million |
+33.19% |
| 2019-12-31 | ₩202.78 Billion ≈ $137.42 Million |
+6.49% |
| 2018-12-31 | ₩190.42 Billion ≈ $129.05 Million |
+13.50% |
| 2017-12-31 | ₩167.77 Billion ≈ $113.70 Million |
-5.27% |
| 2016-12-31 | ₩177.10 Billion ≈ $120.02 Million |
+0.56% |
| 2015-12-31 | ₩176.11 Billion ≈ $119.35 Million |
+44.04% |
| 2013-12-31 | ₩122.27 Billion ≈ $82.86 Million |
-14.97% |
| 2012-12-31 | ₩143.80 Billion ≈ $97.45 Million |
+42.83% |
| 2011-12-31 | ₩100.68 Billion ≈ $68.23 Million |
+104.93% |
| 2007-12-31 | ₩49.13 Billion ≈ $33.29 Million |
+6.10% |
| 2006-12-31 | ₩46.30 Billion ≈ $31.38 Million |
+8.83% |
| 2005-12-31 | ₩42.55 Billion ≈ $28.83 Million |
+33.97% |
| 2004-12-31 | ₩31.76 Billion ≈ $21.52 Million |
-- |
About BINEX Co. Ltd
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; … Read more